SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 515 filers reported holding SEAGEN INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,065,392 | +12.2% | 5,022 | +1.8% | 0.00% | 0.0% |
| Q2 2023 | $949,575 | -14.6% | 4,934 | -10.2% | 0.00% | -20.0% |
| Q1 2023 | $1,112,370 | +32.1% | 5,494 | -16.1% | 0.01% | +25.0% |
| Q4 2022 | $841,870 | +95.8% | 6,551 | +108.6% | 0.00% | +33.3% |
| Q3 2022 | $430,000 | -9.9% | 3,140 | +16.4% | 0.00% | 0.0% |
| Q2 2022 | $477,000 | +39.5% | 2,697 | +13.6% | 0.00% | +50.0% |
| Q1 2022 | $342,000 | +3.3% | 2,375 | +10.9% | 0.00% | 0.0% |
| Q4 2021 | $331,000 | -6.0% | 2,142 | +3.3% | 0.00% | -33.3% |
| Q3 2021 | $352,000 | -3.3% | 2,074 | -10.1% | 0.00% | 0.0% |
| Q2 2021 | $364,000 | +41.1% | 2,307 | +24.2% | 0.00% | 0.0% |
| Q1 2021 | $258,000 | +11.7% | 1,858 | +40.7% | 0.00% | 0.0% |
| Q4 2020 | $231,000 | -40.0% | 1,321 | -32.2% | 0.00% | -50.0% |
| Q3 2020 | $385,000 | – | 1,947 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |